US funding cuts place roughly R2.5 billion of South African research at risk, according to a report by IOL — a figure large enough to reshape portfolio decisions across the country's university and institute system.

The exposure is direct and quantified. Programmes financed from the United States now face withdrawal or reduction, and the R2.5 billion at stake represents committed research capacity, not projected growth. For South African research managers, the question is no longer whether US support will contract, but which grants, programmes and institutional partnerships will absorb the loss first.

The scale matters in context. South Africa's total gross domestic expenditure on research and development has hovered near 0.6% of GDP in recent years, well below the 1% target the government has repeatedly set. Against that baseline, a R2.5 billion withdrawal of US-origin funding removes a meaningful share of the external financing that universities, science councils and medical research units depend on to run laboratories, retain postgraduate researchers and maintain long-running field sites.

The consequences would spread unevenly. Institutions that built research groups around specific US-funded programmes face the hardest choices: terminate staff contracts, wind down cohort studies and clinical follow-ups, or seek replacement funding from South African government departments, European funders and philanthropies on timelines that rarely match payroll obligations. Principal investigators who hold joint appointments or equipment bought under US grant conditions will need to review what the cuts mean for instrument ownership, data rights and publication obligations.

IOL's report frames the risk at the national level, and the headline figure of R2.5 billion is the concrete anchor. What the report does not yet break down — and what research administrators will need within weeks — is the distribution of that exposure: how much sits in health research, how much in climate and biodiversity programmes, and how much in higher-education capacity-building initiatives that US agencies have historically financed. Without that breakdown, universities cannot sequence their responses.

The funding interruption also carries a pipeline cost. Postgraduate students funded through US-supported programmes are typically the first casualties of grant termination. Losing bursary support mid-degree pushes students out of the research workforce at exactly the point where South Africa's National Development Plan has identified skills scarcity as a binding constraint on the innovation system.

There are replacement options, but each has limits. The Department of Science, Technology and Innovation and the National Research Foundation already operate under constrained budgets, and backfilling R2.5 billion would require either reprioritisation within existing allocations or new treasury commitments. European Union framework funding, private foundations and industry-sponsored research offer partial substitutes, but competition for those sources has intensified as other US-dependent systems in Africa and beyond chase the same money.

For R&D managers at South African institutions, the immediate task is a dependency audit: identify every programme with US-origin financing, quantify the annual value, map termination clauses and cost-sharing agreements, and rank programmes by scientific and strategic priority. That exercise converts a headline risk figure into a decision-ready portfolio view.

IOL's reporting signals that the exposure is material and current. How much of the R2.5 billion is ultimately lost, redirected or replaced will depend on negotiations between South African institutions and their US counterparts in the months ahead, and on whether domestic funders move to protect the research capacity now sitting in the gap.